Deutsche Bank Ag\ Otonomy, Inc. Transaction History

Deutsche Bank Ag\

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$1.58 - $4.06 $3,220 - $8,274	-2,038 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$2.13 - $3.83 $694 - $1,248	-326 Reduced 13.79%	2,038 $7,000
Q3 2019 Nov 14, 2019	SELL	$2.12 - $2.86 $76,794 - $103,600	-36,224 Reduced 93.87%	2,364 $5,000
Q2 2019 Aug 14, 2019	SELL	$2.35 - $3.09 $67,402 - $88,627	-28,682 Reduced 42.64%	38,588 $106,000
Q1 2019 May 15, 2019	BUY	$1.8 - $2.97 $65,196 - $107,573	36,220 Added 116.65%	67,270 $176,000
Q4 2018 Feb 14, 2019	SELL	$1.51 - $2.93 $93,094 - $180,640	-61,652 Reduced 66.51%	31,050 $57,000
Q3 2018 Nov 14, 2018	SELL	$2.6 - $3.95 $484,283 - $735,738	-186,263 Reduced 66.77%	92,702 $254,000
Q2 2018 Apr 21, 2020	BUY	$3.7 - $4.75 $80,660 - $103,550	21,800 Added 8.48%	278,965 $1.08 Million
Q2 2018 Aug 14, 2018	SELL	$3.7 - $4.75 $78,225 - $100,424	-21,142 Reduced 7.6%	257,165 $989,000
Q1 2018 Oct 18, 2019	BUY	$4.05 - $6.1 $112,213 - $169,012	27,707 Added 11.06%	278,307 $1.17 Million
Q1 2018 May 15, 2018	SELL	$4.05 - $6.1 $407,349 - $613,538	-100,580 Reduced 28.64%	250,600 $1.05 Million
Q4 2017 Feb 14, 2018	BUY	$2.8 - $5.55 $847,730 - $1.68 Million	302,761 Added 625.29%	351,180 $1.95 Million
Q3 2017 Nov 14, 2017	BUY	$3.2 - $20.8 $154,940 - $1.01 Million	48,419	48,419 $156,000

Ticker OTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,990,400
Description
Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.